alzheimer-s-disease

Documents about alzheimer-s-disease

• Plasma Proteomic Profiles of Alzheimer's Disease and Neurodegeneration in African Cohorts#630343HAL (France)
• Longitudinal plasma phosphorylated tau217 classification and the association with Alzheimer's disease progression.#631108NCBI PubMed Central
• Value-based prices of emerging disease-modifying therapies for Alzheimer's disease in 174 countries: a cost-effectiveness and threshold analysis.#182283NCBI PubMed Central
• Genome‐ and epigenome‐wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk#388316ISTA Publications
• The neural basis of prosocial effort-based decision-making in older adults at risk for Alzheimer's disease#133207bioRxiv / medRxiv
• N-terminally acetylated Met11-Tau: a new pathological truncated Tau species with functional relevance in Alzheimer's disease.#143081NCBI PubMed Central
• Human brain and organoid transcriptomes reveal key receptor tyrosine kinase pathways and genetic signatures in Alzheimer's disease.#159684NCBI PubMed Central
• A biology-based quality-diversity algorithm for drug repurposing in Alzheimer's disease using automated machine learning.#174566NCBI PubMed Central
• Disintegrating ipseity: a gerontological exegesis of Alzheimer's disease and relational identity in Alice Munro's fiction.#275328NCBI PubMed Central
• XIST Self-regulates its Association with THOC2 and the Nuclear Epigenetic Machinery via miR-186 in Alzheimer's disease#403763bioRxiv / medRxiv
• Spatially Resolved Free Fatty Acid Profiling Reveals Region- and Age-Dependent Remodeling of Alzheimer's Disease Plaques.#415376NCBI PubMed Central
• Dual inhibitory potential of N-methylcytisine against GSK-3β and AChE: implications for Alzheimer's disease treatment.#461516NCBI PubMed Central
• Effects of physical exercise on cognitive impairment in patients with Alzheimer's disease, Parkinson's disease or mild cognitive impairment: a systematic review and meta-analysis.#288888NCBI PubMed Central
• “Las formas de olvido y las formas de memoria: los múltiples sentidos en una dinámica familiar que gira en torno al Alzheimer”,#188251Repositorio Institucional Javeriano
• A universal neocortical mask for Centiloid quantification#492045eScholarship
• Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology#273312Europe PMC
• Contextual variability in under-diagnosed cardiometabolic disease and cognitive vulnerability among populations at high risk for Alzheimer’s disease and related dementias.#298749NCBI PubMed Central
• Mortality of People With Alzheimer's Disease and Psychiatric Morbidity: A Nationwide Finnish Cohort Study.#602NCBI PubMed Central
• Sex differences in Alzheimer's disease: a systematic review of two decades of neuroimaging research.#4281NCBI PubMed Central
• Design of a configurable SoC for Alzheimer's disease detection based on multimodal signals.#25824NCBI PubMed Central
• Divergent patterns of cognitive decline in preclinical Alzheimer's disease: Implications for secondary prevention trials.#125279NCBI PubMed Central
• Lifestyle shapes preclinical social and microglial deficits in an Alzheimer's disease mouse model#125776Europe PMC
• Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's disease.#140481NCBI PubMed Central
• SRSF1 as a promising biomarker and key player in the pathogenesis of Alzheimer's disease.#143117NCBI PubMed Central
• Presymptomatic plasma biomarkers in autosomal dominant Alzheimer’s disease: sequence and timing#147926Unpaywall
• Kaempferol Improves Alzheimer's Disease by Inhibiting Neuronal Ferroptosis via Activating GPX4/AKR1C3 Signaling Pathway.#149934NCBI PubMed Central
• The impact of learning about financial compensation on enrollment in Alzheimer's disease longitudinal research.#157888NCBI PubMed Central
• Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease#159167PMC Full-Text (OAI)
• What can artificial intelligence bring to Alzheimer’s disease clinical trials? A first perspective#161340HAL (France)
• Caring for a partner with Alzheimer's disease: Intimacy, loss and the life that is possible#176200Bournemouth University Research Online (BURO)
• Corneal Immune Cell Alterations and Tau Pathology in a Mouse Model of Alzheimer's Disease.#193345NCBI PubMed Central
• Blind Identification of Altered Functional Subnetworks in Alzheimer’s Disease Using Resting-State fMRI.#196064NCBI PubMed Central
• A Balancing Act: Amyloid-β, Tau, and Excitation-Inhibition in Alzheimer's Disease#202223Europe PMC
• Bayesian value-of-infomation analysis: an application to a policy model of Alzheimer's disease#203904White Rose Research Online
• Bayesian value-of-infomation analysis: an application to a policy model of Alzheimer's disease#203944White Rose Research Online
• MC-RVAE: Multi-channel recurrent variational autoencoder for multimodal Alzheimer’s disease progression modelling#218002HAL (France)
• Proteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer's disease.#218808NCBI PubMed Central
• A paradigm of the diagnosis and treatment for the whole process of Alzheimer's disease.#220841NCBI PubMed Central
• Systems genetic dissection of brain gene expression reveals excitotoxic mechanisms of Alzheimer's disease#224187Europe PMC
• Cognitive reserve and gamma entrainment-related network changes in prodromal Alzheimer's disease#234347bioRxiv / medRxiv
• Oxidative stress biomarkers and flavonoids in Alzheimer's disease: current clinical evidence and therapeutic perspectives.#235963NCBI PubMed Central
• MRI-to-PET synthesis via deep learning for amyloid-β quantification in Alzheimer's disease.#236101NCBI PubMed Central
• Longitudinal Sparse Single-Omics Factor Analysis for High-Dimensional Blood Biomarkers in Alzheimer's Disease.#244168NCBI PubMed Central
• Artificial intelligence techniques for classification of Alzheimer's disease using neuroimaging data: a review.#251324NCBI PubMed Central
• Gene-Modulated Network Diffusion for Improved Modeling of Amyloid-β Spread in Alzheimer's Disease#261160bioRxiv / medRxiv
• The myth of digital biomarkers in Alzheimer's disease: how to make them a reality.#262889NCBI PubMed Central
• A dynamic risk prediction framework for Alzheimer's disease and related dementias with interpretability.#275498NCBI PubMed Central
• Use of Artificial Intelligence for the Early Detection and Prediction of Alzheimer’s Disease.#288954NCBI PubMed Central
• Neurotransmitter-based machine-learning model for distinguishing Alzheimer's disease and mild cognitive impairment.#305350NCBI PubMed Central
• mTORC2-Na(v)1.2 signaling drives early hyperexcitability in Alzheimer's disease mouse model.#308737NCBI PubMed Central